Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
    • Subscribe
Advertisement

Article

January 1, 2022

The Top 5 Cancer-Related Podcast Episodes of 2021

Author(s):

Jamie Cesanek

CURE® compiled its top 5 most-listened-to podcast episodes from this year, featuring cancer survivor stories, caregivers and experts.

This year, CURE®’s “Cancer Horizons” podcast shared the incredible stories of cancer survivors and caregivers, heard powerful words of inspiration from advocates and discussed the ins and outs of cancer research with some of the leading cancer experts.

We compiled the most-listened-to episodes from 2021 for our audience. They are:

1. A Family’s Journey with Ovarian Cancer, Genetic Testing and the BRCA1 Mutation

In this heartfelt episode, an ovarian cancer survivor shares the story of her cancer journey, which includes undergoing genetic testing that revealed she was a BRCA1 carrier. Her daughter joins her in the conversation, explaining how she decided to take preventative surgical measures to avert a cancer diagnosis.

2. The Unique Dynamic of a Mother-Daughter Cancer-Caregiver Relationship

A mother-daughter duo who host a podcast together joined CURE® in this episode to discuss their cancer journey and how it led them to creating their podcast, “Stage 4 Clinger,” which takes a humorous look at their situation.

3. Survivor Lives in Gratitude Despite Ovarian Cancer

A teacher who is a survivor of ovarian cancer shares her story in this podcast episode, explaining how she used humor to get through treatment and why remaining connected to friends and family is the key to getting through the darkest of days.

4. The Double Whammy of Cancer and COVID-19 on Mental Health

An expert from Memorial Sloan Kettering Cancer Center joins CURE® in this podcast episode to discuss the impacts of the COVID-19 pandemic on mental health for patients with cancer, survivors and caregivers, and offers some advice on how people can manage these strains.

5. Gleevec Turned the Clock on a Late-Stage Leukemia Diagnosis

Leukemia survivor Mel Mann shared his fascinating cancer story of how joining a clinical trial for Gleevec (imatinib) turned his late-stage diagnosis around and has led him to continue living a happy life nearly 27 years later.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Evaluation and Diagnosis of Multiple Myeloma
Evaluation and Diagnosis of Multiple Myeloma
Introduction and Overview of Multiple Myeloma
Introduction and Overview of Multiple Myeloma
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
How ADCs Are Redefining Chemotherapy in Breast Cancer Care
Image of women with text.
Understanding Novel Therapy Utility in HER2+ Breast Cancer Treatment
Dr. Breelyn Wilky urged newly diagnosed GIST patients to seek support from peers and advocacy groups, and to consult experts, even if care stays local.
Second Opinions Key for Those Newly Diagnosed With GIST
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.
Understanding the Science Behind the Monjuvi Approval in Lymphoma
Clinical Trial Evaluating Monjuvi in Lymphoma Gives Lasting Responses
Clinical Trial Evaluating Monjuvi in Lymphoma Gives Lasting Responses
Survivors can find strength after cancer by focusing on goals, loved ones, and spiritual connection, especially during challenging or uncertain times.
Finding Strength and Purpose After Cancer Through Goals and Faith
Image of man with text.
How Survivorship Differs for Men With Metastatic Prostate Cancer
Image of man with text.
How Does CAR T-Cell Therapy Work in Hematologic Malignancies?
Related Content
Advertisement
Image of man with text.
July 15th 2025

Refining Treatment Approaches and Advancements in High-Risk Melanoma

Ryan Scott
Dr. Vincent Ma discussed the most recent and notable treatment updates for patients with high-risk and advanced melanoma.
The Importance of Spotting Endometrial Cancer
March 18th 2025

The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
Bria-IMT plus a checkpoint inhibitor improved survival versus Trodelvy and chemo in patients with heavily pretreated metastatic breast cancer: © stock.adobe.com.
July 15th 2025

Bria-IMT Improves Survival in Patients With Metastatic Breast Cancer

Spencer Feldman
Bria-IMT plus a checkpoint inhibitor improved survival versus Trodelvy and chemo in patients with heavily pretreated metastatic breast cancer.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
Monjuvi added to Rituxan and Revlimid extended progression-free survival from 14 to 22 months in follicular lymphoma: © stock.adobe.com.
July 14th 2025

Monjuvi Combo Reduces Progression Risk in Follicular Lymphoma

Spencer Feldman
Monjuvi added to Rituxan and Revlimid extended progression-free survival from 14 to 22 months in follicular lymphoma, according to Dr. Christina Poh.
Bonnie Annis is a breast cancer survivor, diagnosed in 2014 with stage 2b invasive ductal carcinoma with metastasis to the lymph nodes. Catch up on all of Bonnie's blogs here!
July 14th 2025

The Power of Suggestion in Breast Cancer Prevention

Bonnie Annis
A subtle ad about breast cancer self-checks led me to reflect on my own experience and the complex role of pharmaceutical companies in awareness.
Related Content
Advertisement
Image of man with text.
July 15th 2025

Refining Treatment Approaches and Advancements in High-Risk Melanoma

Ryan Scott
Dr. Vincent Ma discussed the most recent and notable treatment updates for patients with high-risk and advanced melanoma.
The Importance of Spotting Endometrial Cancer
March 18th 2025

The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
Bria-IMT plus a checkpoint inhibitor improved survival versus Trodelvy and chemo in patients with heavily pretreated metastatic breast cancer: © stock.adobe.com.
July 15th 2025

Bria-IMT Improves Survival in Patients With Metastatic Breast Cancer

Spencer Feldman
Bria-IMT plus a checkpoint inhibitor improved survival versus Trodelvy and chemo in patients with heavily pretreated metastatic breast cancer.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
Monjuvi added to Rituxan and Revlimid extended progression-free survival from 14 to 22 months in follicular lymphoma: © stock.adobe.com.
July 14th 2025

Monjuvi Combo Reduces Progression Risk in Follicular Lymphoma

Spencer Feldman
Monjuvi added to Rituxan and Revlimid extended progression-free survival from 14 to 22 months in follicular lymphoma, according to Dr. Christina Poh.
Bonnie Annis is a breast cancer survivor, diagnosed in 2014 with stage 2b invasive ductal carcinoma with metastasis to the lymph nodes. Catch up on all of Bonnie's blogs here!
July 14th 2025

The Power of Suggestion in Breast Cancer Prevention

Bonnie Annis
A subtle ad about breast cancer self-checks led me to reflect on my own experience and the complex role of pharmaceutical companies in awareness.
Advertisement
Advertisement
Advertisement
x
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.